Expert insights. Personalized for you.
Medicine Related Topics 
MedCity News
JULY 27, 2022
A panel discussion on the future of digital medicine highlighted some of the collaborations taking place between pharma companies and digital health, as well as some of the challenges facing the push towards mainstream implementation.
World of DTC Marketing
DECEMBER 4, 2020
Digital medicine has been thrust into the spotlight because of the pandemic and the media hype is in overdrive. A study of some 16m American ones just reported in jama Internal Medicine , a journal, found that their use of telemedicine surged 30-fold between January and June.
PharmExec
SEPTEMBER 15, 2022
In episode 117, Helen Sabzevari, CEO of Precigen, discusses her drive to study science as a Persian-born woman, the opportunities she’s had to research immunology, and how she’s now developing next-generation CAR-T treatments for cancer, in addition to other therapies.
Pharma Leaders
SEPTEMBER 15, 2022
In episode 117, Helen Sabzevari, CEO of Precigen, discusses her drive to study science as a Persian-born woman, the opportunities she’s had to research immunology, and how she’s now developing next-generation CAR-T treatments for cancer, in addition to other therapies. Compliance Channel Posts
.png)
MedCity News
AUGUST 30, 2022
Health data company CuriMeta launched on Tuesday and announced the close of a $6 million seed funding round led by its two institutional partners, BJC HealthCare and the Washington University School of Medicine.
PharmaTech
JUNE 16, 2022
The new draft guidance describes a standards recognition program for regenerative medicine therapies.
PharmExec
AUGUST 10, 2022
Failed efforts do not overshadow field’s progress, resolve.
MedCity News
AUGUST 9, 2022
The Penn Medicine-Wharton Fund for Health, Penn’s venture fund focused on social determinants of health, recently announced investments in its fifth and sixth companies.
European Pharmaceutical Review
SEPTEMBER 21, 2022
Biosimilar medicine Ximluci (ranibizumab) for the treatment of neovascular age-related macular degeneration, a progressive retinal macular disease, causing gradual vision impairment, mainly in the elderly population. 11 medicines for indication extension.
European Pharmaceutical Review
AUGUST 10, 2022
In order to meet microbiological quality standards, herbal medicine pills are often irradiated at the primary package or final product stage. Pills are a popular formulation of herbal medicines, such as Traditional Chinese medicine (TCM) or Kampo medicine from China or Japan.
Pharmaceutical Technology
JULY 1, 2022
Blueprint Medicines has entered strategic financing partnerships for up to $1.25bn with life sciences-focused investors Sixth Street and Royalty Pharma. The post Blueprint Medicines announces financing partnerships for $1.25bn appeared first on Pharmaceutical Technology.
PharmExec
AUGUST 10, 2022
Major stakeholders—including policymakers, public-private interests, and academia—are increasingly embracing the potential of proteomics technology in reshaping diagnostics and patient care.
PharmaTech
JULY 18, 2022
The European Medicines Agency guidance highlights key principles and examples of good practices to prevent and manage shortages of human medicines.
Pharma Phorum
JULY 5, 2022
Sanofi has said it will make 30 of its most commonly prescribed medicines available at non-profit prices to 40 lower-income countries, as part of a global health initiative launched by the company last year.
Pharmaceutical Technology
AUGUST 11, 2022
Gemini Therapeutics has signed a definitive agreement to merge with Disc Medicine in an all-stock deal to create a clinical-stage biopharmaceutical company. The merged company is expected to be named Disc Medicine, which will have corporate headquarters in Watertown, Massachusetts, US.
InCrowd
JULY 6, 2022
How can this narrative be a form of medicine? Columbia University describes narrative medicine as “an interdisciplinary field that brings powerful narrative skills of radical listening and creativity from the humanities and the arts to address the needs of all who seek and deliver health care.
Pharma Leaders
AUGUST 17, 2022
The post Senda raises funds to advance programmable medicines platform development appeared first on Pharmaceutical Business review.
World of DTC Marketing
JUNE 5, 2021
The post Obesity represents a catastrophic failure of government policy, public health, and medicine. SUMMARY: Obesity has many causes, and while we would like to think the answer is as easy as people exercising more and eating less, it isn’t that simple.
Pharma Leaders
SEPTEMBER 20, 2022
The post FDA accepts for priority review Seagen’s sNDA for colorectal cancer medicine appeared first on Pharmaceutical Business review.
Pharma Phorum
JULY 5, 2022
Using drones will cut the transit time for the medicines from four hours to 30 minutes, and will also require less fuel – an increasingly important consideration as prices rocket at petrol pumps. The post NHS England trials first medicine deliveries by drone appeared first on.
European Pharmaceutical Review
JULY 19, 2022
Transpire Bio and Recipharm have signed a definitive agreement for the development of TRB-1 and TRB-2 – two inhaled medicines for the treatment of asthma and Chronic Obstructive Pulmonary Disease (COPD). We are very excited to be working with Recipharm to advance these important medicines.”.
Pharmaceutical Technology
JULY 5, 2022
Through the Impact brand, which comprises insulin, glibenclamide and oxaliplatin among others, the company will supply its 30 medicines in 40 lower-income countries in the world. The post Sanofi unveils global health brand for medicines supply appeared first on Pharmaceutical Technology.
Pharma Pathway
SEPTEMBER 5, 2022
Aurigene Pharmaceutical Services Limited-Walk-In Drive for R&D Medicinal Chemistry On 11th Sept’ 2022. Aurigene Pharmaceutical Services Limited-Walk-In Drive for R&D Medicinal Chemistry On 11th Sept’ 2022 @ Hyderabad & Bangalore. Aurigene Pharmaceutical Services Limited-Walk-In Drive for R&D Medicinal Chemistry On 11th Sept’ 2022. Job Description.
Pharmaceutical Technology
JULY 22, 2022
Sangamo Therapeutics has received orphan medicinal product designation (OMPD) from the European Commission (EC) for its Investigational autologous Chimeric Antigen Receptor Regulatory T Cell (CAR-Treg) cell therapy, TX200, for solid organ transplantation.
European Pharmaceutical Review
JULY 5, 2022
The Impact ® brand includes 30 Sanofi medicines and covers a wide range of therapeutic areas, including diabetes, cardiovascular disease, tuberculosis, malaria and cancer. Medicines include insulin, glibenclamide and oxaliplatin, the company said.
Pharmacy Times
AUGUST 9, 2022
Study suggests that health care providers should discuss with patients whether they are using any integrative medicine strategies, which ones, and why.
PharmExec
SEPTEMBER 12, 2022
The integration of the "Amplion knowledgebase" and next-generation data architecture will immediately expand Science & Medicine Group's capabilities to deliver more comprehensive, actionable insights to commercial organizations at life science equipment and reagent manufacturers as well as pharmaceutical services providers. us
MedCity News
AUGUST 7, 2022
The need for precision medicine in the reproductive health care sphere has never been greater: for much of the country, the risks of unwanted pregnancy are exacerbated by abortion legislation and unscientific political rhetoric around birth control.
Pharma Phorum
SEPTEMBER 8, 2022
Lucy’s story shows how the promise of precision medicine doesn’t always line up with the profit motive and economies of scale in the healthcare industry. Patients Podcast R&D Video Views & Analysis Views and analysis Moonshots for Unicorns PGAP3-CDG precision medicine Rare diseases
Pharmaceutical Technology
JULY 7, 2022
But scientists have struggled to find effective treatments for many of these diseases since the dawn of modern medicine. It is certainly a pivotal moment for the cell and gene industry, with the next decade of R&D and clinical trials expected to transform the future of medicine.
Copyright Clearance Center
AUGUST 9, 2022
The JAMA Network brings JAMA together with JAMA Network Open and 11 specialty medical journals to offer enhanced access to the research, reviews, and opinions shaping the future of medicine. August 9, 20 22 – Danvers, Mass. –
European Pharmaceutical Review
JULY 20, 2022
Our research paper, which is being submitted for publication this summer, aims to create an evidence-based medicine (EBM) methodology that can assess this positive impact, to further help regulators determine appropriate risk minimisation measures. ketoconazole – an antifungal medicine.
PharmExec
AUGUST 10, 2022
The road to precision medicine as a fixture in healthcare delivery is still a journey, but recent advances and new understandings in gene profiling, biomarker development, and AI and data analytics are steadily bringing these therapies closer to the individual patient every day.
European Pharmaceutical Review
AUGUST 23, 2022
FAKE MEDICINES are not a new problem, and pose a tremendous threat to patient safety and public health in society regardless of a country’s economic status. Some, 250,000 child deaths per year can be attributed to counterfeit malaria and pneumonia medicines. Counterfeit medicines.
Pharma Leaders
JULY 29, 2022
This licence enables the least developed, low-income, lower middle-income as well as Sub-Saharan African countries to access the long-acting HIV prevention medicine.
PharmaTech
JUNE 17, 2022
MHRA has been accepted as a full member of three international work-sharing partnerships aimed at making sure medicines and medical devices are regulated safely and efficiently across the world.
Teachntest
JANUARY 20, 2022
Homeopathic Pharmacy: A Natural Alternative to Modern Medicine. With the rise in technological innovation and the push towards a more Westernized lifestyle, we’ve begun to forget about the natural remedies that our ancestors relied on for centuries.
Pharma Leaders
JULY 1, 2022
The post Mesh Bio, MultiOmic partner to develop chronic metabolic disease medicines appeared first on Pharmaceutical Business review. As part of the collaboration, the companies will carry out an observational study in chronic metabolic disease patients as well as those with increased risk of complications like. Industry News
MedCity News
AUGUST 16, 2022
Biotech startup Senda Biosciences is developing technology that yields a new type of medicine with two programming components: one directs the therapy to go to a particular destination in the body while the second tells the therapy what to do once it gets there.
Pharmacy Times
JULY 20, 2022
What we're seeing as a trend is this significant increase in synthetic opioids, specifically fentanyl, being contaminated and causing severe overdoses.
85 
Let's personalize your content